Home›Stock Screener›Nirman Agri Genetics›Financial Statements

Nirman Agri Genetics Financial Statements

6 Years of Data
2026 - 2021

Nirman Agri Genetics financial statements. In FYNone, Nirman Agri Genetics (NIRMAN) reported revenue ₹237 Cr, net profit ₹25 Cr and EPS ₹33.50, with a net profit margin of 9.1% and ROE of 14.1%. Full financial statements from FY2021 to FY2026 (6 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Read Nirman Agri Genetics dividend payments for the complete payout history and dividend yield track record.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 9.14% 2026 data
EBITDA Margin 9.64% 2026 data
Operating Margin 10.00% 2026 data
Return on Assets 13.95% 2026 data
Return on Equity 14.06% 2026 data

Balance Sheet Ratios

Equity Ratio 99.22% 2026 data
Asset Turnover 1.53 2026 data

NIRMAN Revenue, Net Profit & EBITDA — Year-on-Year Growth

NIRMAN YoY (March 2026 vs Period) — revenue +20.3%, net profit +38.9%, EBITDA +42.1%, expenses +18.0%. For live price, earnings ratios and company overview, see NIRMAN share price screener.

Revenue Growth
+20.3%
Year-over-Year
Net Profit Growth
+38.9%
Year-over-Year
EBITDA Growth
+42.1%
Year-over-Year
Expense Growth
+18.0%
Year-over-Year
Assets Growth
+14.2%
Year-over-Year
Equity Growth
+16.4%
Year-over-Year
Operating Cash Flow Growth
+21.9%
Year-over-Year
Investing Cash Flow Growth
-100.0%
Year-over-Year
Financing Cash Flow Growth
-102.2%
Year-over-Year

NIRMAN Income Statement — Revenue, EBITDA & Net Profit

Nirman Agri Genetics revenue ₹237 Cr, EBITDA ₹27 Cr, net profit ₹25 Cr, EPS ₹33.50 (None) — net profit margin 9.1%. Analyse Nirman Agri Genetics ownership structure to track promoter, FII and institutional holdings.

Periods ₹ Crores
Particulars None March 2026 March 2025 March 2024 March 2023 March 2022 March 2021
Revenue 237 197 237 63 29 14 4
Expenses 210 178 210 52 24 10 4
EBITDA 27 19 27 11 4 3 0
Operating Profit Margin % 11.00% 10.00% 11.00% 18.00% 15.00% 25.00% 2.00%
Depreciation 1 1 1 0 0 0 0
Interest 0 0 0 0 0 0 0
Profit Before Tax 26 18 26 11 4 3 0
Tax 1 1 1 1 0 1 0
Net Profit 25 18 25 10 4 3 0
Earnings Per Share (₹) 33.50 21.98 31.57 12.99 10.24 2560.20 54.70

NIRMAN Balance Sheet — Assets, Liabilities & Shareholders' Equity

NIRMAN total assets ₹129 Cr, total equity ₹128 Cr, total liabilities ₹ Cr (2026) — ROE 14.1%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021
ASSETS
Total Assets 129 113 44 30 6 2
Current Assets 118 101 22 9 6 2
Fixed Assets 2 2 0 1 0 0
Capital Work in Progress 0 0 0 0 0 0
Investments 0 0 0 0 0 0
Other Assets 128 111 44 29 6 2
LIABILITIES
Total Liabilities
Current Liabilities 0 0 0 1 1 1
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 128 110 37 27 3 0
Share Capital 8 8 6 6 0 0
Reserves & Surplus 120 102 31 21 3 0

NIRMAN Cash Flow Statement — Operating, Investing & Financing

Nirman Agri Genetics operating cash flow ₹-25 Cr, investing ₹0 Cr, financing ₹-1 Cr, net cash flow ₹-25 Cr (2026).

Periods ₹ Crores
Particulars March 2026 March 2025 March 2024 March 2023 March 2022 March 2021
Operating Activities -25 -32 4 0 0 0
Investing Activities 0 10 -2 -21 0 0
Financing Activities -1 46 -1 20 0 1
Net Cash Flow -25 24 1 -1 0 1